Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

ANIP

ANI Pharmaceuticals Inc

Dec 01 • 04:00PM ET

50.57

Dollar change +0.76
Percentage change 1.53	%

Healthcare • Drug Manufacturers - Specialty & Generic • USA • NASD

Stock Detail • Compare Perf. • Options Chain • Save to Portfolio • Create Alert

Scroll to Statements

Index	RUT	P/E	83.85	EPS (ttm)	0.60	Insider Own	21.11%	Shs Outstand	17.49M	Perf Week	-2.47%
Market Cap	1.03B	Forward P/E	11.86	EPS next Y	4.26	Insider Trans	-14.86%	Shs Float	16.12M	Perf Month	-17.99%
Income	11.76M	PEG	38.11	EPS next Q	0.78	Inst Own	67.62%	Short Float / Ratio	2.34% / 2.23	Perf Quarter	-21.69%
Sales	449.39M	P/S	2.30	EPS this Y	225.74%	Inst Trans	2.88%	Short Interest	0.38M	Perf Half Y	5.35%
Book/sh	21.07	P/B	2.40	EPS next Y	-3.76%	ROA	1.64%	Target Price	71.00	Perf Year	20.55%
Cash/sh	9.45	P/C	5.35	EPS next 5Y	2.20%	ROE	3.49%	52W Range	36.36 - 65.89	Perf YTD	25.70%
Dividend	-	P/FCF	17.20	EPS past 5Y	-102.25%	ROI	1.59%	52W High	-23.25%	Beta	0.89
Dividend %	-	Quick Ratio	2.91	Sales past 5Y	13.49%	Gross Margin	50.27%	52W Low	39.08%	ATR	1.97
Employees	600	Current Ratio	3.70	Sales Q/Q	57.27%	Oper. Margin	10.20%	RSI (14)	37.24	Volatility	3.05% 4.15%
Optionable	Yes	Debt/Eq	0.72	EPS Q/Q	190.24%	Profit Margin	2.62%	Rel Volume	0.95	Prev Close	49.81
Shortable	Yes	LT Debt/Eq	0.72	Earnings	Nov 08 BMO	Payout	-	Avg Volume	169.05K	Price	50.57
Recom	1.00	SMA20	-6.38%	SMA50	-10.95%	SMA200	-0.15%	Volume	160,791	Change	1.53%

Date	Action	Analyst	Rating Change	Price Target Change
Aug-22-23	Reiterated	H.C. Wainwright	Buy	$60 → $73
Mar-01-23	Initiated	Guggenheim	Buy	$55
Sep-07-22	Initiated	H.C. Wainwright	Buy	$50
Nov-02-21	Initiated	Truist	Buy	$70
May-07-20	Downgrade	Cantor Fitzgerald	Overweight → Neutral
Sep-12-19	Initiated	Guggenheim	Buy
May-10-19	Downgrade	Raymond James	Strong Buy → Outperform	$73 → $82
Oct-16-17	Reiterated	Canaccord Genuity	Buy	$60 → $66
Jul-31-17	Initiated	Canaccord Genuity	Buy	$60
Feb-22-17	Downgrade	ROTH Capital	Buy → Neutral
Jun-23-16	Initiated	Raymond James	Strong Buy	$68
May-24-16	Downgrade	Standpoint Research	Buy → Hold
Nov-13-15	Initiated	Standpoint Research	Buy	$54
Sep-28-15	Upgrade	ROTH Capital	Neutral → Buy	$67 → $60
Aug-05-15	Reiterated	Oppenheimer	Outperform	$74 → $65
Aug-04-15	Reiterated	ROTH Capital	Neutral	$70 → $67
Jul-31-15	Reiterated	Oppenheimer	Outperform	$72 → $74
Jul-15-15	Reiterated	ROTH Capital	Neutral	$60 → $70
Jun-23-15	Reiterated	Oppenheimer	Outperform	$61 → $67
May-18-15	Reiterated	ROTH Capital	Neutral	$78 → $60

Show Previous Ratings

Nov-22-23 09:26AM	ANI Pharmaceuticals to Present at the Piper Sandler 35th Annual Healthcare Conference (GlobeNewswire)
Nov-19-23 07:00AM	A Boring Biopharma Can Be a Good Bet (TheStreet.com)
Nov-17-23 05:11AM	Insider Sell Alert: SVP, CHIEF HR OFFICER Krista Davis Sells Shares of ANI Pharmaceuticals Inc (GuruFocus.com)
Nov-09-23 09:42AM	ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) Q3 2023 Earnings Call Transcript (Insider Monkey)
Nov-08-23 03:11PM	ANI Pharmaceuticals Inc (ANIP) Reports Record Q3 2023 Results; Raises Full-Year Guidance (GuruFocus.com) -14.64%
09:30AM	Loading…
09:30AM	Compared to Estimates, ANI (ANIP) Q3 Earnings: A Look at Key Metrics (Zacks)
07:08AM	ANI: Q3 Earnings Snapshot (Associated Press Finance)
06:50AM	ANI Pharmaceuticals Reports Record Third Quarter 2023 Financial Results and Raises Full-Year 2023 Guidance (GlobeNewswire)
Nov-02-23 10:00AM	Poseida Therapeutics, Inc. (PSTX) Expected to Beat Earnings Estimates: Can the Stock Move Higher? (Zacks)
Nov-01-23 06:00PM	ANI Pharmaceuticals (ANIP) Stock Drops Despite Market Gains: Important Facts to Note (Zacks)
10:01AM	ANI Pharmaceuticals (ANIP) Earnings Expected to Grow: What to Know Ahead of Next Week's Release (Zacks)
Oct-30-23 06:50AM	ANI Pharmaceuticals to Participate at Two Upcoming Healthcare Conferences (GlobeNewswire)
Oct-25-23 06:50AM	ANI Pharmaceuticals to Discuss Third Quarter 2023 Financial Results on November 8, 2023, at 8:30 a.m. ET (GlobeNewswire)
Oct-20-23 06:00PM	ANI Pharmaceuticals (ANIP) Increases Despite Market Slip: Here's What You Need to Know (Zacks)
Oct-19-23 06:15PM	ANI Pharmaceuticals (ANIP) Stock Moves -0.14%: What You Should Know (Zacks)
06:00PM	Loading…
Oct-13-23 06:00PM	ANI Pharmaceuticals (ANIP) Stock Moves -0.48%: What You Should Know (Zacks)
Oct-06-23 06:00PM	ANI Pharmaceuticals (ANIP) Stock Sinks As Market Gains: Here's Why (Zacks)
Oct-05-23 06:15PM	(ANIP) Advances While Market Declines: Some Information for Investors (Zacks)
Oct-02-23 06:50AM	ANI Pharmaceuticals Announces FDA Approval and Commercial Availability of New 1-mL Vial Size of Purified Cortrophin Gel, Appropriate for Adjunctive Treatment of Certain Patients with Acute Gouty Arthritis Flares (GlobeNewswire)
Sep-29-23 06:00PM	ANI Pharmaceuticals (ANIP) Dips More Than Broader Markets: What You Should Know (Zacks)
Sep-22-23 04:19AM	Mirati (MRTX) Soars 12.3%: Is Further Upside Left in the Stock? (Zacks)
Sep-21-23 06:00PM	ANI Pharmaceuticals (ANIP) Dips More Than Broader Markets: What You Should Know (Zacks)
Sep-20-23 06:15PM	ANI Pharmaceuticals (ANIP) Stock Moves -0.9%: What You Should Know (Zacks)
Sep-18-23 04:05PM	ANI Pharmaceuticals to Present at the Cantor Global Healthcare Conference 2023 (GlobeNewswire)
Sep-14-23 06:00PM	ANI Pharmaceuticals (ANIP) Outpaces Stock Market Gains: What You Should Know (Zacks)
Sep-12-23 06:50AM	ANI Pharmaceuticals Announces the FDA Approval and Launch of Estradiol Tablets USP (GlobeNewswire)
Sep-11-23 02:43PM	Here's Why You Should Add ANI Pharmaceuticals (ANIP) to Your Portfolio (Zacks)
Sep-08-23 08:50AM	ANI (ANIP) Is a Great Choice for 'Trend' Investors, Here's Why (Zacks)
Aug-29-23 09:15AM	ANI Pharmaceuticals, Inc. (ANIP) Hits Fresh High: Is There Still Room to Run? (Zacks)
Aug-28-23 06:50AM	ANI Pharmaceuticals Announces the FDA Approval and Launch of Estradiol Gel, 0.1% (GlobeNewswire)
12:00PM	Loading…
Aug-25-23 12:00PM	What Makes ANI (ANIP) a New Strong Buy Stock (Zacks)
10:00AM	Best Momentum Stocks to Buy for August 25th (Zacks)
06:39AM	New Strong Buy Stocks for August 25th (Zacks)
Aug-24-23 06:50AM	ANI Pharmaceuticals to Present at the H.C. Wainwright 25th Annual Global Investment Conference (GlobeNewswire)
Aug-23-23 08:50AM	Here's Why Momentum in ANI (ANIP) Should Keep going (Zacks)
06:50AM	ANI Pharmaceuticals Appoints Healthcare Executive Matthew J. Leonard to its Board of Directors (GlobeNewswire)
Aug-16-23 09:15AM	Eton Pharmaceuticals, Inc. (ETON) Hits Fresh High: Is There Still Room to Run? (Zacks)
Aug-11-23 09:40AM	Is Amphastar Pharmaceuticals (AMPH) Stock Outpacing Its Medical Peers This Year? (Zacks)
Aug-10-23 09:15AM	ANI Pharmaceuticals, Inc. (ANIP) Hit a 52 Week High, Can the Run Continue? (Zacks)
Aug-09-23 09:30AM	ANI (ANIP) Reports Q2 Earnings: What Key Metrics Have to Say (Zacks) +9.21%
08:15AM	ANI Pharmaceuticals (ANIP) Beats Q2 Earnings and Revenue Estimates (Zacks)
07:06AM	ANI: Q2 Earnings Snapshot (AP Finance)
06:50AM	ANI Pharmaceuticals Reports Record Second Quarter 2023 Financial Results and Raises Full-Year 2023 Guidance (GlobeNewswire)
Jul-31-23 11:06AM	ANI Pharmaceuticals (ANIP) to Post Q2 Earnings: What's in Store? (Zacks)
07:17AM	ANI Pharmaceuticals to Discuss Second Quarter 2023 Financial Results on August 9, 2023, at 8:30 a.m. ET (GlobeNewswire)
Jul-24-23 06:00PM	ANI Pharmaceuticals (ANIP) Outpaces Stock Market Gains: What You Should Know (Zacks)
Jul-18-23 06:00PM	ANI Pharmaceuticals (ANIP) Outpaces Stock Market Gains: What You Should Know (Zacks)
09:40AM	Are Medical Stocks Lagging ANI Pharmaceuticals (ANIP) This Year? (Zacks)
Jul-11-23 06:15PM	ANI Pharmaceuticals (ANIP) Gains But Lags Market: What You Should Know (Zacks)
Jun-27-23 07:12AM	ANI Pharmaceuticals, Inc. (NASDAQ:ANIP): Is Breakeven Near? (Simply Wall St.)
Jun-22-23 09:40AM	Are Medical Stocks Lagging ANI Pharmaceuticals (ANIP) This Year? (Zacks)
Jun-21-23 08:00PM	ANIP: Raising target price to $55.00 (Argus Research)
09:15AM	ANI Pharmaceuticals, Inc. (ANIP) Hits Fresh High: Is There Still Room to Run? (Zacks)
Jun-20-23 11:31AM	AstraZeneca (AZN) May Reportedly Spin-Off its Chinese Business (Zacks)
Jun-06-23 12:37PM	Those who invested in ANI Pharmaceuticals (NASDAQ:ANIP) a year ago are up 69% (Simply Wall St.)
09:40AM	Is Bellerophon Therapeutics (BLPH) Outperforming Other Medical Stocks This Year? (Zacks)
May-22-23 06:34PM	ANI Pharmaceuticals to Present at the Jefferies Healthcare Conference (Business Wire)
May-18-23 09:40AM	Is ANI Pharmaceuticals (ANIP) Outperforming Other Medical Stocks This Year? (Zacks)
May-16-23 04:05PM	ANI Pharmaceuticals Announces Closing of Public Offering of Common Stock Including Full Exercise of Underwriters Option to Purchase Additional Shares (Business Wire) +8.32%
May-15-23 06:50AM	ANI Pharmaceuticals Announces FDA Approval and Commercialization of Two ANDAs with CGT Exclusivity (Business Wire)
May-12-23 07:03AM	ANI Pharmaceuticals Announces Pricing of $75 Million Public Offering of Common Stock (Business Wire) -5.19%
May-11-23 04:01PM	ANI Pharmaceuticals Announces Proposed Public Offering of Common Stock (Business Wire)
May-09-23 02:32AM	Q1 2023 ANI Pharmaceuticals Inc Earnings Call (Thomson Reuters StreetEvents)
May-08-23 01:17PM	Why ANI Pharmaceuticals Stock Is Soaring Today (Benzinga) +8.79%
08:05AM	ANI Pharmaceuticals (ANIP) Beats Q1 Earnings and Revenue Estimates (Zacks)
06:50AM	ANI Pharmaceuticals Reports Record First Quarter 2023 Financial Results and Raises Full-Year 2023 Guidance (Business Wire)
Apr-27-23 06:50AM	ANI Pharmaceuticals to Discuss First Quarter 2023 Financial Results on May 8, 2023, at 8:30 a.m. ET (Business Wire)
Apr-26-23 08:00PM	ANIP: Lowering target price to $39.00 (Argus Research)
04:15PM	ANI Pharmaceuticals to Present at the H.C. Wainwright BioConnect Investor Conference at NASDAQ (Business Wire)
Apr-24-23 06:50AM	ANI Pharmaceuticals Announces the FDA Approval and Launch of Nitrofurantoin Oral Suspension USP (Business Wire)
Apr-15-23 09:08AM	ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) is largely controlled by institutional shareholders who own 60% of the company (Simply Wall St.)
Apr-04-23 06:50AM	ANI Pharmaceuticals Announces the FDA Approval of Colestipol Hydrochloride Tablets USP (Business Wire)
Mar-13-23 07:06AM	New Strong Sell Stocks for March 13th (Zacks)
Mar-09-23 11:45PM	Q4 2022 ANI Pharmaceuticals Inc Earnings Call (Thomson Reuters StreetEvents)
08:05AM	ANI Pharmaceuticals (ANIP) Q4 Earnings and Revenues Top Estimates (Zacks)
06:50AM	ANI Pharmaceuticals Reports Record Fourth Quarter Financial Results and Achieves Full Year 2022 Revenue Milestone; Initiates 2023 Guidance (Business Wire)
Mar-02-23 10:00AM	ANI Pharmaceuticals (ANIP) Earnings Expected to Grow: Should You Buy? (Zacks)
Mar-01-23 04:16PM	Guggenheim Creates Bullish Pitch For ANI Pharma On Progress With Cortrophin Launch (Benzinga)
Feb-28-23 05:35PM	Mirati (MRTX) Reports Q4 Loss, Misses Revenue Estimates (Zacks)
Feb-22-23 04:05PM	ANI Pharmaceuticals to Discuss Fourth Quarter and Full Year 2022 Financial Results on March 9, 2023, at 8:30 a.m. ET (Business Wire)
Feb-07-23 06:39AM	Bullish ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) insiders filled their treasuries with US$752k worth of stock over last year (Simply Wall St.)
Dec-22-22 07:19AM	The past five years for ANI Pharmaceuticals (NASDAQ:ANIP) investors has not been profitable (Simply Wall St.)
Dec-19-22 04:56PM	ANI Pharmaceuticals Announces the FDA Approval and Launch of Levocarnitine Tablets USP (Business Wire)
Nov-28-22 06:50AM	ANI Pharmaceuticals Announces the FDA Approval and Launch of Fluoxetine Oral Solution USP (Business Wire)
Nov-27-22 09:31AM	This Biopharma 'Fits the Bill' as a Growth Play (TheStreet.com)
Nov-16-22 06:50AM	ANI Pharmaceuticals Announces the FDA Approval and Launch of Trimethoprim Tablets USP (Business Wire)
Nov-11-22 05:25AM	ANI Pharmaceuticals Third Quarter 2022 Earnings: Revenues Beat Expectations, EPS Lags (Simply Wall St.)
Nov-09-22 08:05AM	ANI Pharmaceuticals (ANIP) Surpasses Q3 Earnings and Revenue Estimates (Zacks) -9.20%
06:50AM	ANI Pharmaceuticals Reports Third Quarter 2022 Financial Results; Reports Record Net Revenues (Business Wire)
Oct-24-22 06:50AM	ANI Pharmaceuticals to Discuss Third Quarter 2022 Financial Results on November 9, 2022, at 8:00 a.m. ET (Business Wire)
Sep-12-22 06:50AM	ANI Pharmaceuticals Appoints Krista Davis as Chief Human Resources Officer (Business Wire)
Aug-31-22 06:59AM	Bullish ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) insiders filled their treasuries with US$1.0m worth of stock over last year (Simply Wall St.)
Aug-30-22 04:05PM	ANI Pharmaceuticals to Present at the H.C. Wainwright 24th Annual Global Investment Conference (Business Wire)
Aug-29-22 06:50AM	ANI Pharmaceuticals Announces the Launch of Prochlorperazine Maleate Tablets USP (Business Wire)
Aug-16-22 06:50AM	ANI Pharmaceuticals Announces FDA Approval and Imminent Launch of Dexamethasone Tablets USP (Business Wire)
Aug-08-22 08:05AM	ANI Pharmaceuticals (ANIP) Tops Q2 Earnings and Revenue Estimates (Zacks)
06:50AM	ANI Pharmaceuticals Reports Second Quarter 2022 Financial Results; Reports Record Net Revenues and Raises Full-Year 2022 Net Revenue Guidance for Purified Cortrophin® Gel (Business Wire)
Aug-04-22 01:15PM	Should You Buy ANI Pharmaceuticals (ANIP) Ahead of Earnings? (Zacks)
Aug-03-22 06:50AM	ANI Pharmaceuticals Announces the Launch of Acebutolol Hydrochloride Capsules USP (Business Wire)
Aug-02-22 10:00AM	IDEAYA Biosciences, Inc. (IDYA) Expected to Beat Earnings Estimates: Should You Buy? (Zacks)

ANI Pharmaceuticals, Inc. is a bio-pharmaceutical company, which engages in developing, manufacturing, and marketing branded and generic prescription pharmaceuticals. Its areas of product development include narcotics, oncolytics, hormones and steroids, and complex formulations involving extended release and combination products. The company was founded on August 29, 1996 and is headquartered in Baudette, MN.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Shanmugam Muthusamy	HEAD OF R&D, COO-NOVITIUM OPS	Nov 17	Sale	51.00	13,000	663,000	982,620	Nov 20 09:05 PM
Shanmugam Muthusamy	HEAD OF R&D, COO-NOVITIUM OPS	Nov 16	Sale	51.66	6,448	333,104	996,430	Nov 16 06:11 PM
Shanmugam Muthusamy	HEAD OF R&D, COO-NOVITIUM OPS	Nov 15	Sale	53.64	7,647	410,185	1,002,878	Nov 16 06:11 PM
Davis Krista	SVP, CHIEF HR OFFICER	Nov 15	Sale	53.81	2,622	141,090	32,587	Nov 16 06:13 PM
Shanmugam Muthusamy	HEAD OF R&D, COO-NOVITIUM OPS	Nov 14	Sale	53.17	22,095	1,174,791	1,010,525	Nov 16 06:11 PM
Mutz Christopher	HEAD OF RARE DISEASE	Nov 10	Sale	52.47	3,000	157,410	63,607	Nov 13 04:02 PM
Shanmugam Muthusamy	HEAD OF R&D, COO-NOVITIUM OPS	Oct 19	Sale	57.06	10,000	570,600	1,032,620	Oct 19 04:28 PM
Shanmugam Muthusamy	HEAD OF R&D, COO-NOVITIUM OPS	Oct 18	Sale	57.78	6,242	360,663	1,042,620	Oct 19 04:28 PM
Shanmugam Muthusamy	HEAD OF R&D, COO-NOVITIUM OPS	Oct 17	Sale	58.53	8,758	512,606	1,048,862	Oct 19 04:28 PM
Shanmugam Muthusamy	HEAD OF R&D, COO-NOVITIUM OPS	Oct 16	Sale	58.31	13,063	761,704	1,057,620	Oct 17 04:32 PM
Shanmugam Muthusamy	HEAD OF R&D, COO-NOVITIUM OPS	Oct 13	Sale	57.58	11,937	687,332	1,070,683	Oct 17 04:32 PM
Gassert Chad	SVP - CORP. DEV. & STRATEGY	Oct 02	Sale	56.48	20,000	1,129,600	293,226	Oct 03 08:00 PM
Shanmugam Muthusamy	HEAD OF R&D, COO-NOVITIUM OPS	Sep 19	Sale	61.23	25,333	1,551,140	1,082,620	Sep 19 05:14 PM
Shanmugam Muthusamy	HEAD OF R&D, COO-NOVITIUM OPS	Sep 18	Sale	61.64	8,425	519,317	1,107,953	Sep 19 05:14 PM
Shanmugam Muthusamy	HEAD OF R&D, COO-NOVITIUM OPS	Sep 15	Sale	62.81	16,242	1,020,160	1,116,378	Sep 19 05:14 PM
Gassert Chad	SVP - CORP. DEV. & STRATEGY	Sep 01	Sale	64.70	20,000	1,294,000	313,226	Sep 05 05:06 PM
Shanmugam Muthusamy	HEAD OF R&D, COO-NOVITIUM OPS	Aug 29	Sale	63.37	25,000	1,584,250	1,132,620	Aug 30 04:29 PM
Shanmugam Muthusamy	HEAD OF R&D, COO-NOVITIUM OPS	Aug 28	Sale	63.06	25,000	1,576,500	1,157,620	Aug 30 04:29 PM
Gutwerg Ori	SVP, GENERICS	Aug 23	Option Exercise	31.49	13,502	425,178	76,476	Aug 25 04:22 PM
Marken James G.	SVP OPS & PROD DEV	Aug 23	Option Exercise	38.25	5,417	207,224	137,044	Aug 25 04:17 PM
Gutwerg Ori	SVP, GENERICS	Aug 23	Sale	62.39	15,561	970,851	60,915	Aug 25 04:22 PM
Marken James G.	SVP OPS & PROD DEV	Aug 23	Sale	63.00	3,932	247,716	133,112	Aug 25 04:17 PM
MERIDIAN VENTURE PARTNERS II L	10% Owner	Aug 16	Sale	58.50	200,000	11,700,000	1,819,259	Aug 16 08:00 PM
Lalwani Nikhil	PRESIDENT & CEO	Aug 15	Option Exercise	29.00	11,616	336,864	365,006	Aug 15 08:39 PM
Shanmugam Muthusamy	HEAD OF R&D, COO-NOVITIUM OPS	Aug 15	Sale	61.60	22,110	1,361,976	1,182,620	Aug 16 07:07 PM
Lalwani Nikhil	PRESIDENT & CEO	Aug 15	Sale	61.13	11,616	710,086	353,390	Aug 15 08:39 PM
Shanmugam Muthusamy	HEAD OF R&D, COO-NOVITIUM OPS	Aug 14	Sale	61.15	27,890	1,705,474	1,204,730	Aug 16 07:07 PM
CAREY STEPHEN P.	SVP & CFO	Aug 14	Sale	61.37	17,639	1,082,505	155,839	Aug 16 04:24 PM
Pera Antonio R	Director	Aug 14	Sale	60.37	3,000	181,110	33,627	Aug 15 08:45 PM
Lalwani Nikhil	PRESIDENT & CEO	Aug 11	Sale	57.75	56,666	3,272,462	353,390	Aug 15 08:39 PM
Gassert Chad	SVP - CORP. DEV. & STRATEGY	Aug 01	Sale	51.06	20,000	1,021,200	333,226	Aug 03 06:03 PM
Shanmugam Muthusamy	HEAD OF R&D, COO-NOVITIUM OPS	Jul 21	Sale	52.56	11,500	604,440	1,232,620	Jul 21 07:15 PM
Shanmugam Muthusamy	HEAD OF R&D, COO-NOVITIUM OPS	Jul 20	Sale	51.52	6,000	309,120	1,244,120	Jul 21 07:15 PM
Shanmugam Muthusamy	HEAD OF R&D, COO-NOVITIUM OPS	Jul 19	Sale	51.48	5,969	307,284	1,250,120	Jul 21 07:15 PM
Shanmugam Muthusamy	HEAD OF R&D, COO-NOVITIUM OPS	Jul 18	Sale	51.84	6,700	347,328	1,256,089	Jul 18 08:06 PM
Shanmugam Muthusamy	HEAD OF R&D, COO-NOVITIUM OPS	Jul 17	Sale	51.06	9,831	501,971	1,262,789	Jul 18 08:06 PM
Shanmugam Muthusamy	HEAD OF R&D, COO-NOVITIUM OPS	Jul 14	Sale	50.43	10,000	504,300	1,272,620	Jul 18 08:06 PM
Gassert Chad	SVP - CORP. DEV. & STRATEGY	Jul 03	Sale	53.43	20,000	1,068,600	353,226	Jul 06 04:15 PM
Gassert Chad	SVP - CORP. DEV. & STRATEGY	Jun 22	Sale	51.32	20,000	1,026,400	373,226	Jun 23 08:00 PM
Shanmugam Muthusamy	HEAD OF R&D, COO-NOVITIUM OPS	Jun 22	Sale	51.38	13,500	693,630	7,407	Jun 22 08:00 PM
Shanmugam Muthusamy	HEAD OF R&D, COO-NOVITIUM OPS	Jun 21	Sale	51.95	11,843	615,244	20,907	Jun 22 08:00 PM
Shanmugam Muthusamy	HEAD OF R&D, COO-NOVITIUM OPS	Jun 20	Sale	51.93	14,657	761,138	32,750	Jun 22 08:00 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

ANIP

ANI Pharmaceuticals Inc

Upgrade your FINVIZ experience